Get started
Author

Adrien Lannes

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
2016 · Jérôme Boursier, Julien Vergniol, et al. · Journal of Hepatology · 412
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
2018 · Richard Moreau, Laure Elkrief, et al. · Gastroenterology · 169
PDF
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
2019 · Jérôme Boursier, Maeva Guillaume, et al. · Journal of Hepatology · 159
PDF
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
2022 · Jérôme Boursier, Clémence M. Canivet, et al. · Clinical Gastroenterology and Hepatology · 113
A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis
2017 · Jérôme Boursier, Victor de Ledinghen, et al. · Journal of Hepatology · 99
PDF
Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non‐alcoholic fatty liver disease from tertiary care centres
2019 · Maeva Guillaume, Valerie Moal, et al. · Alimentary Pharmacology & Therapeutics · 56
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
2021 · Pierre Nahon, Marie Najean, et al. · JHEP Reports · 55
PDF
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
2019 · Arthur Berger, Sarah Shili, et al. · Clinical and Translational Gastroenterology · 55
PDF
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
2022 · Clémence M. Canivet, Charlotte Costentin, et al. · Hepatology · 50
Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease
2023 · Norma David, Jean-Philippe Antignac, et al. · Environment International · 47
A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD
2024 · Paul Calès, Clémence M. Canivet, et al. · Journal of Hepatology · 44
PDF
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population
2018 · Matthieu Wargny, Pierre-Henri Ducluzeau, et al. · Atherosclerosis · 44
MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis
2024 · Carole Vitellius, Elvire Desjonqueres, et al. · JHEP Reports · 37
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trial
2025 · Jean-Paul Cervoni, Delphine Weil, et al. · The Lancet. Gastroenterology & hepatology · 33
Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting
2025 · Anaïs Cardon, Thomas Guinebretière, et al. · Nature Communications · 25
PDF
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder
2024 · Lucile Moga, Valérie Paradis, et al. · Hepatology · 24
Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease
2021 · Jérôme Boursier, Maeva Guillaume, et al. · Clinics and Research in Hepatology and Gastroenterology · 22
A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-CO
2021 · Arthur Berger, Elodie Cesbron-Métivier, et al. · Clinics and Research in Hepatology and Gastroenterology · 22
PDF
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests
2023 · Jérôme Boursier, Marine Roux, et al. · Nature Communications · 17
PDF
Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification
2018 · Jerome Boursier, Christophe Cassinotto, et al. · Clinical Gastroenterology and Hepatology · 16
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
2022 · Georges-Philippe Pageaux, Clovis Lusivika Nzinga, et al. · BMC Infectious Diseases · 15
PDF
Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners
2021 · Clémence M. Canivet, Sarra Smati, et al. · Clinics and Research in Hepatology and Gastroenterology · 14
PDF
Cross‐linkage between bacterial taxonomy and gene functions: a study of metagenome‐assembled genomes of gut microbiota in adult non‐alcoholic fatty liver disease
2021 · Clemence M. Canivet, Norma David, et al. · Alimentary Pharmacology & Therapeutics · 13
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes
2026 · Yuping Chen, Bingtian Dong, et al. · Gut · 10
Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients
2019 · Thomas Broussier, Adrien Lannes, et al. · Clinics and Research in Hepatology and Gastroenterology · 10
Works count: 71
Citation count: 1,612
H-index: 18
I10-index: 25
Year
Topic
Type